RNA-seq analysis of liver cancer patients' plasma

Accession: GSE142987
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Genetic/Epigenetic, subtype: cfDNA/liquid biopsy)
Modality / assay: cfdna-liquidbiopsy
Platform: Expression profiling by high throughput sequencing, GPL20795
Organism: human
Samples: 65
Size (indexed): 2.7 MB (2797803 bytes)
Downloaded bytes: 2.7 MB (2797803 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE142987_sample_count_matrix.txt.gz2.7 MB5ec77b5ed3648f1b…

Index note: 1 file(s); GSE142987_sample_count_matrix.txt.

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:51:29Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL20795 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 65 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.